Viatris Inc. Files 8-K for Routine Disclosures
Ticker: VTRS · Form: 8-K · Filed: Sep 4, 2024 · CIK: 1792044
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Viatris filed an 8-K for standard disclosures, no major news.
AI Summary
On September 4, 2024, Viatris Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond routine disclosures were detailed in the provided text.
Why It Matters
This filing indicates Viatris Inc. is meeting its regulatory reporting obligations. Investors should review the full filing for any specific updates or disclosures beyond what is summarized here.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any significant new risks or material adverse events.
Key Players & Entities
- Viatris Inc. (company) — Registrant
- Upjohn Inc. (company) — Former Company Name
- September 4, 2024 (date) — Date of Report
- 1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317 (location) — Principal Executive Offices Address
FAQ
What is the primary purpose of this 8-K filing by Viatris Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on September 4, 2024.
What is Viatris Inc.'s principal executive office address?
Viatris Inc.'s principal executive office is located at 1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317.
What was Viatris Inc.'s former company name?
Viatris Inc.'s former company name was Upjohn Inc.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 686 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-09-04 07:46:56
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share VTRS The NASDAQ Stock Mar
- $450,000,000 — lan (the "Mylan Notes") and (iii) up to $450,000,000 aggregate principal amount of the outst
Filing Documents
- form8-k.htm (8-K) — 32KB
- ex99-1.htm (EX-99.1) — 46KB
- image0.jpg (GRAPHIC) — 16KB
- 0000950157-24-001164.txt ( ) — 242KB
- vtrs-20240904.xsd (EX-101.SCH) — 4KB
- vtrs-20240904_lab.xml (EX-101.LAB) — 21KB
- vtrs-20240904_pre.xml (EX-101.PRE) — 16KB
- form8-k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On September 4, 2024, Viatris Inc. (the "Company") issued a press release (the "Tender Offer Press Release") announcing that it and its subsidiaries Mylan Inc. ("Mylan") and Utah Acquisition Sub Inc. ("Utah Acquisition") have commenced offers to purchase for cash (the "Tender Offers") (i) any and all of the outstanding 1.650% Senior Notes due 2025 issued by the Company (the "Viatris Notes"), (ii) any and all of the outstanding 2.125% Senior Notes due 2025 issued by Mylan (the "Mylan Notes") and (iii) up to $450,000,000 aggregate principal amount of the outstanding 3.950% Senior Notes due 2026 issued by Utah Acquisition (the "Utah Acquisition Notes"). The Tender Offers are subject to the terms and conditions set forth in the Offer to Purchase dated September 4, 2024. To the extent that less than all of the outstanding Viatris Notes and Mylan Notes are tendered and accepted for purchase in the Tender Offers, the Company and Mylan, respectively and as applicable, currently intend to (but are not obligated to) cause the applicable indenture corresponding to the Viatris Notes to be satisfied and discharged in accordance with the terms thereof and solely with respect to the Viatris Notes and redeem any remaining Mylan Notes in accordance with the terms of the applicable indenture corresponding to the Mylan Notes. A copy of the Tender Offer Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. 99.1 Press release dated September 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIATRIS INC. Date: September 4, 2024 by: /s/ Theodora Mistras Name: Theodora Mistras Title: Chief Financial Officer